Kurt Yun Mou (Yun Mou)

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 19

Top Venues

EMBO molecular medicine

eLife

ACS synthetic biology

Journal of the American Chemical Society

University of California San Francisco

California Institute of Technology (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of California San Francisco Apr 06 2015

United States

Postdoctoral Researcher :: Pharmaceutical Chemistry

California Institute of Technology Jul 01 2014 - Mar 31 2015

United States

Postdoctoral Researcher :: Biology and Biological Engineering

Education History

California Institute of Technology Sep 01 2007 - May 31 2014

United States

PHD :: Chemistry

National Taiwan University Sep 01 2004 - Jul 01 2006

Taiwan

MSC :: Chemistry

National Taiwan University Sep 01 2000 - Jul 01 2004

Taiwan

BSC :: Chemistry

Publications

See-Khai Lim, Wen-Ching Lin, Sin-Wei Huang, Yi-Chung Pan, Che-Wei Hu, Chung-Yuan Mou, Che-Ming Jack Hu, Kurt Yun Mou
Bacteria colonization in tumor microenvironment creates a favorable niche for immunogenic chemotherapy. EMBO molecular medicine (2024)
See-Khai Lim, Wen-Ching Lin, Sin-Wei Huang, Yi-Chung Pan, Che-Wei Hu, Chung-Yuan Mou, Che-Ming Jack Hu, Kurt Yun Mou
Bacteria colonization in tumor microenvironment creates a favorable niche for immunogenic chemotherapy. EMBO molecular medicine (2024)
See-Khai Lim, Wen-Ching Lin, Sin-Wei Huang, Yi-Chung Pan, Che-Wei Hu, Chung-Yuan Mou, Che-Ming Jack Hu, Kurt Yun Mou
Bacteria colonization in tumor microenvironment creates a favorable niche for immunogenic chemotherapy. EMBO molecular medicine 16 (2) (2024)
See-Khai Lim, Wen-Ching Lin, Sin-Wei Huang, Yi-Chung Pan, Che-Wei Hu, Chung-Yuan Mou, Che-Ming Jack Hu, Kurt Yun Mou
Bacteria colonization in tumor microenvironment creates a favorable niche for immunogenic chemotherapy. EMBO molecular medicine 16 (2) (2024)
Sin-Wei Huang, See-Khai Lim, Yao-An Yu, Yi-Chung Pan, Wan-Ju Lien, Chung-Yuan Mou, Che-Ming Jack Hu, Kurt Yun Mou
Overcoming the nutritional immunity by engineering iron-scavenging bacteria for cancer therapy. eLife 12 (2024)
Sin-Wei Huang, See-Khai Lim, Yao-An Yu, Yi-Chung Pan, Wan-Ju Lien, Chung-Yuan Mou, Che-Ming Jack Hu, Kurt Yun Mou
Overcoming the nutritional immunity by engineering iron-scavenging bacteria for cancer therapy. eLife 12 (2024)
See-Khai Lim, Wen-Ching Lin, Sin-Wei Huang, Yi-Chung Pan, Che-Wei Hu, Chung-Yuan Mou, Che-Ming Jack Hu, Kurt Yun Mou
Bacteria colonization in tumor microenvironment creates a favorable niche for immunogenic chemotherapy. EMBO molecular medicine 16 (2) (2024)
See-Khai Lim, Wen-Ching Lin, Sin-Wei Huang, Yi-Chung Pan, Che-Wei Hu, Chung-Yuan Mou, Che-Ming Jack Hu, Kurt Yun Mou
Bacteria colonization in tumor microenvironment creates a favorable niche for immunogenic chemotherapy. EMBO molecular medicine 16 (2) (2024)
Sin-Wei Huang, See-Khai Lim, Yao-An Yu, Yi-Chung Pan, Wan-Ju Lien, Chung-Yuan Mou, Che-Ming Jack Hu, Kurt Yun Mou
Overcoming the nutritional immunity by engineering iron-scavenging bacteria for cancer therapy. eLife 12 (2024)
Chia-Yi Kao, Yi-Chung Pan, Yi-Hsiang Hsiao, See-Khai Lim, Ting-Wei Cheng, Sin-Wei Huang, Shania Meng-Yun Wu, Cheng-Pu Sun, Mi-Hua Tao, Kurt Yun Mou
Improvement of Gene Delivery by Minimal Bacteriophage Particles. ACS nano (2023)
Wen-Ching Lin, Hao-Cheng Tang, Han Ying Wang, Chia-Yi Kao, You-Chiun Chang, Athena Hsu Li, Shi-Bing Yang, Kurt Yun Mou
Fragment-Directed Random Mutagenesis by the Reverse Kunkel Method. ACS synthetic biology 11 (4) (2022)
Han Ying Wang, You-Chiun Chang, Che-Wei Hu, Chia-Yi Kao, Yao-An Yu, See-Khai Lim, Kurt Yun Mou
Development of a Novel Cytokine Vehicle Using Filamentous Phage Display for Colorectal Cancer Treatment. ACS synthetic biology 10 (8) (2021)
Cheng-Hao Liu, Jen-Hsuan Chang, You-Chiun Chang, Kurt Yun Mou
Treatment of murine colitis by Saccharomyces boulardii secreting atrial natriuretic peptide. Journal of molecular medicine (Berlin, Germany) 98 (12) (2020)
You-Chiun Chang, Chia-Yi Kao, Hao-Cheng Tang, Meng-Sen Huang, Kurt Yun Mou
Direct Antibody Isolation on Cells Using Affinity-Tag-Guided Proximity Selection. Biochemistry 59 (44) (2020)
Meng-Sen Huang, Jen-Hsuan Chang, Wen-Ching Lin, Yu-Hsiang Cheng, Fu-An Li, Ching-Shu Suen, Ming-Jing Hwang, Chung-Ke Chang, Kurt Yun Mou
SLC38A2 Overexpression Induces a Cancer-like Metabolic Profile and Cooperates with SLC1A5 in Pan-cancer Prognosis. Chemistry, an Asian journal 15 (22) (2020)
Xin X Zhou, Colton J Bracken, Kaihua Zhang, Jie Zhou, Kurt Yun Mou, Lei Wang, Yifan Cheng, Kevin K Leung, James A Wells
Targeting Phosphotyrosine in Native Proteins with Conditional, Bispecific Antibody Traps. Journal of the American Chemical Society 142 (41) (2020)
Cheng-Hao Liu, Ming-Jou Chien, You-Chiun Chang, Yu-Hsiang Cheng, Fu-An Li, Kurt Yun Mou
Combining Proximity Labeling and Cross-Linking Mass Spectrometry for Proteomic Dissection of Nuclear Envelope Interactome. Journal of proteome research 19 (3) (2020)
Meng-Sen Huang, Wen-Ching Lin, Jen-Hsuan Chang, Cheng-Hung Cheng, Han Ying Wang, Kurt Yun Mou
The cysteine-free single mutant C32S of APEX2 is a highly expressed and active fusion tag for proximity labeling applications. Protein science : a publication of the Protein Society 28 (9) (2019)
Kurt Yun Mou, Xin X Zhou, Kevin Leung, Alexander J Martinko, Jiun-Yann Yu, Wentao Chen, James A Wells
Engineering Improved Antiphosphotyrosine Antibodies Based on an Immunoconvergent Binding Motif. Journal of the American Chemical Society 140 (48) (2018)

Kurt Yun Mou.css-eqlu8i{font-size:small;padding-left:4px;} (Yun Mou)

Publication Activity (10 Years)

Top Topics

Top Venues

Kurt Yun Mou (Yun Mou)